Dan Leonard
Stock Analyst at RBC Capital
(4.60)
# 891
Out of 4,361 analysts
499
Total ratings
58.2%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Initiated Coverage: Buy | $165 → $153 | $135.05 | +13.29% | 35 | May 26, 2026 | |
| BIO Bio-Rad Laboratories | Initiated Coverage: Buy | $335 → $320 | $306.13 | +4.53% | 29 | May 14, 2026 | |
| DHR Danaher | Initiated Coverage: Buy | $270 → $200 | $176.11 | +13.57% | 26 | May 14, 2026 | |
| ILMN Illumina | Initiated Coverage: Buy | $135 → $170 | $162.55 | +4.58% | 40 | May 14, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $195 → $160 | $121.13 | +32.09% | 3 | May 14, 2026 | |
| TECH Bio-Techne | Initiated Coverage: Buy | $79 → $62 | $49.77 | +24.57% | 20 | May 14, 2026 | |
| TMO Thermo Fisher Scientific | Initiated Coverage: Hold | $615 → $490 | $482.08 | +1.64% | 27 | May 14, 2026 | |
| AVTR Avantor | Initiated Coverage: Hold | $11 → $9 | $8.99 | +0.11% | 12 | May 14, 2026 | |
| BRKR Bruker | Rated: Hold | $40 → $45 | $57.31 | -21.48% | 24 | May 7, 2026 | |
| CERT Certara | Rated: Buy | $15 → $10 | $5.62 | +77.94% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $290 | $212.73 | +36.32% | 17 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $170 → $175 | $174.79 | +0.12% | 19 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $130.17 | +34.44% | 17 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $20 | $30.71 | -34.87% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $355 → $340 | $312.17 | +8.92% | 6 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $360 → $370 | $371.93 | -0.52% | 23 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $52 | $35.69 | +45.70% | 17 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $240 | $180.64 | +32.86% | 17 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $13 | $15.74 | -20.58% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $220 | $137.56 | +59.93% | 7 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $28 | $18.79 | +49.02% | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $300 → $305 | $445.59 | -31.55% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1,530 → $1,350 | $1,170.00 | n/a | 14 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $120 → $115 | $100.39 | n/a | 18 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $20 | $18.70 | n/a | 6 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 | $4.83 | n/a | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 960.00 | $838.94 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 → $7 | $15.14 | n/a | 2 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 → $320 | $257.70 | n/a | 15 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $160 → $145 | $193.16 | n/a | 15 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 → $95 | $115.05 | n/a | 7 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.0001 | n/a | 1 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $35 | $4.31 | n/a | 14 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $144.43 | n/a | 1 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.002 | n/a | 5 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $47.80 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.07 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $86.97 | n/a | 1 | Jun 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.0001 | n/a | 4 | May 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.5 | $1.51 | n/a | 3 | May 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $15 | $1.16 | n/a | 11 | Apr 12, 2016 |
Agilent Technologies
May 26, 2026
Initiated Coverage: Buy
Price Target: $165 → $153
Current: $135.05
Upside: +13.29%
Bio-Rad Laboratories
May 14, 2026
Initiated Coverage: Buy
Price Target: $335 → $320
Current: $306.13
Upside: +4.53%
Danaher
May 14, 2026
Initiated Coverage: Buy
Price Target: $270 → $200
Current: $176.11
Upside: +13.57%
Illumina
May 14, 2026
Initiated Coverage: Buy
Price Target: $135 → $170
Current: $162.55
Upside: +4.58%
Repligen
May 14, 2026
Initiated Coverage: Buy
Price Target: $195 → $160
Current: $121.13
Upside: +32.09%
Bio-Techne
May 14, 2026
Initiated Coverage: Buy
Price Target: $79 → $62
Current: $49.77
Upside: +24.57%
Thermo Fisher Scientific
May 14, 2026
Initiated Coverage: Hold
Price Target: $615 → $490
Current: $482.08
Upside: +1.64%
Avantor
May 14, 2026
Initiated Coverage: Hold
Price Target: $11 → $9
Current: $8.99
Upside: +0.11%
Bruker
May 7, 2026
Rated: Hold
Price Target: $40 → $45
Current: $57.31
Upside: -21.48%
Certara
Mar 9, 2026
Rated: Buy
Price Target: $15 → $10
Current: $5.62
Upside: +77.94%
Feb 27, 2026
Maintained: Buy
Price Target: $280 → $290
Current: $212.73
Upside: +36.32%
Feb 25, 2026
Maintained: Hold
Price Target: $170 → $175
Current: $174.79
Upside: +0.12%
Feb 20, 2026
Reiterated: Buy
Price Target: $175
Current: $130.17
Upside: +34.44%
Feb 19, 2026
Maintained: Hold
Price Target: $14 → $20
Current: $30.71
Upside: -34.87%
Feb 13, 2026
Maintained: Buy
Price Target: $355 → $340
Current: $312.17
Upside: +8.92%
Feb 10, 2026
Maintained: Hold
Price Target: $360 → $370
Current: $371.93
Upside: -0.52%
Feb 9, 2026
Maintained: Hold
Price Target: $52
Current: $35.69
Upside: +45.70%
Feb 6, 2026
Maintained: Buy
Price Target: $280 → $240
Current: $180.64
Upside: +32.86%
Nov 5, 2025
Maintained: Buy
Price Target: $11 → $13
Current: $15.74
Upside: -20.58%
Oct 24, 2025
Maintained: Buy
Price Target: $260 → $220
Current: $137.56
Upside: +59.93%
Aug 6, 2025
Maintained: Hold
Price Target: $24 → $28
Current: $18.79
Upside: +49.02%
Jul 29, 2025
Downgraded: Sell
Price Target: $300 → $305
Current: $445.59
Upside: -31.55%
May 19, 2025
Upgraded: Buy
Price Target: $1,530 → $1,350
Current: $1,170.00
Upside: n/a
May 1, 2025
Upgraded: Buy
Price Target: $120 → $115
Current: $100.39
Upside: n/a
Mar 2, 2025
Maintained: Hold
Price Target: $25 → $20
Current: $18.70
Upside: n/a
Aug 8, 2024
Maintained: Hold
Price Target: $11
Current: $4.83
Upside: n/a
Apr 8, 2024
Maintained: Hold
Price Target: kr 960.00
Current: $838.94
Upside: n/a
Feb 14, 2023
Maintained: Sell
Price Target: $8 → $7
Current: $15.14
Upside: n/a
Feb 11, 2022
Maintained: Buy
Price Target: $340 → $320
Current: $257.70
Upside: n/a
Feb 4, 2022
Maintained: Hold
Price Target: $160 → $145
Current: $193.16
Upside: n/a
Oct 18, 2021
Maintained: Buy
Price Target: $86 → $95
Current: $115.05
Upside: n/a
Jul 14, 2020
Initiated Coverage: Buy
Price Target: $11
Current: $0.0001
Upside: n/a
Aug 14, 2019
Maintained: Hold
Price Target: $45 → $35
Current: $4.31
Upside: n/a
Dec 6, 2018
Initiated Coverage: Buy
Price Target: $280
Current: $144.43
Upside: n/a
Jul 8, 2016
Reiterated: Buy
Price Target: $7
Current: $0.002
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $47.80
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $22.07
Upside: n/a
Jun 16, 2016
Rated: Hold
Price Target: n/a
Current: $86.97
Upside: n/a
May 23, 2016
Reiterated: Buy
Price Target: $4
Current: $0.0001
Upside: n/a
May 11, 2016
Reiterated: Hold
Price Target: $4.5 → $3.5
Current: $1.51
Upside: n/a
Apr 12, 2016
Maintained: Buy
Price Target: $20 → $15
Current: $1.16
Upside: n/a